Commerce Dashboard

SERUM INSTITUTE OF INDIA

Go Back

SERUM INSTITUTE OF INDIA

  • Founded in 1966 with the aim to manufacture immune biologicals, which were short in India and imported at higher prices.
  • Manufactures life-saving biologicals at affordable prices.
  • Serum vaccines are used in ~170 countries in their national immunization programmes.

Serum Institute of India Pvt. Ltd. manufactures several vaccines, which include Polio, Diphtheria, Tetanus, Pertussis, Hib, BCG, r-Hepatitis B, Measles, Mumps and Rubella vaccines. 65% children in the world are estimated to receive at least one vaccine manufactured by Serum Institute. Vaccines manufactured by the Serum Institute are accredited by the World Health Organization.

Source: http://www.seruminstitute.com/

Serum Institute of India – Protection from birth onwards

2021

In June 2021, SII announced plans to launch Novavax's COVID-19 vaccine 'Covovax' in India by September 2021

Government of India signed a deal to procure 20 million doses of its COVID-19 vaccination.
2020

Launched India’s first fully indigenously developed pneumococcal vaccine, 'Pneumosil'

2016 Launched world’s first rabies human monoclonal antibody, recombinant
2014 Launched oral polio vaccine
2012 Acquired Bilthoven Biologicals, Netherlands
Launched Trivalent seasonal influenza vaccine
2011 Launched injectable inactivated polio vaccine
2010 Launched H1N1 influenza vaccine
2009 Launched liquid pentavalent vaccine (DPT-HepB-Hib) (PENAVAC SD/PFS)
2007 Launched Hib vaccine and BCG vaccine for bladder cancer
2002 Launched BCG vaccine
2001 Launched Hepatitis B vaccine
1993 Launched MMR vaccine
1989 Launched measles vaccine
1974 Commenced production of DTP vaccine

 

Biotechnology
The biotechnology industry in India comprises >2700 biotech start-ups and is estimated to reach 10,000 by 2024.